CWD · CaliberCos
The AI's read
CaliberCos reported Q2 with a 10% decline in platform revenue but platform adjusted EBITDA turned positive and management reaffirmed $18M–$22M revenue guidance. They also announced a first fund tokenization and showed project progress, which matter for future capital formation. The market has already punished the headline: CWD is down ~-5.24% and RSI is 22.54, so some of the downside is priced in. At the same time the tokenization and EBITDA improvement are real optionality that the market may not fully value for a tiny cap. Bottom line: we lean mixed. The story is balanced between execution risk and genuine optionality, so upside requires follow-through on tokenizations and project financings while downside remains significant for a microcap.